Brief: Entrada Therapeutics Reports Q4, Full Year 2021 Financial Results
15/03/2022 11:15
March 15 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS
* ENTRADA THERAPEUTICS INC - $291.1 MILLION IN CASH AND CASH
EQUIVALENTS AS OF DECEMBER 31, 2021 TO ADVANCE PIPELINE OF
EEV-THERAPEUTIC CANDIDATES
* ENTRADA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.89
Source text for Eikon: ID:nGNX1yGYKB
Further company coverage: TRDA.O
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview